Consensus Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Market Closed - Toronto S.E. Other stock markets 03:59:59 2024-04-23 pm EDT			5-day change	1st Jan Change
8.81 ^CAD	+5.01%		-1.12%	+59.03%

Mar. 15	Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
Mar. 14	Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.	CI

Evolution of the average Target Price on Cipher Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

7fa9ab584c9e1ed2810eee557e0e49c1.H_IpS3Flp0Flsr0oteqAWp951O3svfJ0mP4txd6w0hc.RoB8BilT1CY_3PZc2L7MFqookbiI8ZAEx71fqOjDq3JokUw-N0jmBDaB5A~ad10de8fc0e70f81b5110008e3f5efc7

Analyst Recommendations on Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Upgraded to Buy at Stifel GMP; Price Target Raised to C$8.00	Feb. 14	MT
Cipher Pharmaceuticals Upgraded to Speculative Buy at Stifel GMP; Price Target Raised to C$4.75	23-06-02	MT